ESPERION THERAPEUTICS INC


Updates from The Motley Fool

Latest updates on Esperion Therapeutics from Fool.com.
Why Chimerix Inc. Is Up Big Today

Shares are recovering today from their massive sell-off, but the company's near-term future remai...



Stock Performance

View Interactive ESPR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Esperion Therapeutics.
Current Price: $49.37
Prev Close: $49.67
Open: $49.76
Bid: $47.50
Ask: $51.70
Day's Range: $48.85 - $49.82
52wk Range: $9.40 - $57.38
Volume: 233,165
Avg Vol 750,791
Market Cap: $1B
P/E (ttm): -8.59
EPS (ttm): ($5.78)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Esperion Therapeutics.
CAPS Rating 3 out of 5
 
72 Outperform
10 Underperform
CAPS All Stars
 
18 Outperform
2 Underperform

How do you think Esperion Therapeutics will perform against the market?



You pick for Esperion Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Esperion Therapeutics.

ESPERION THERAPEUTICS INC

  • Exchange: NASDAQ